1. Market Research
  2. > Pharmaceutical
  3. > Therapy
  4. > Oncology Market Trends
  5. > Oncology Industry in Europe Market Research & Statistics

Oncology Industry in Europe Market Research & Statistics

About 100 reports

Download Unlimited Documents from Trusted Public Sources

Global Oncology Market

  • September 2017
    14 pages
  • Cancer  

  • Europe  

    World  

    European Union  

View report >

Oncology Market in Europe and India - Forecast

  • July 2017
    11 pages
  • Oncology  

    Pharmaceutical  

    Cancer  

  • Europe  

    India  

    World  

View report >

Oncology Market - Forecast

  • January 2017
    6 pages
  • Oncology  

  • Sweden  

    Europe  

    United States  

View report >

Global Oncology Market

  • January 2017
    14 pages
  • Cancer  

  • Europe  

    World  

    European Union  

View report >

Therapy Market in the UK and Europe

  • May 2018
    15 pages
  • Therapy  

    Chemotherapy  

  • United Kingdom  

    Europe  

View report >

Global Biosimilar Overview

  • March 2018
    28 pages
  • Biosimilar  

    Therapy  

    Pharmaceutical  

  • World  

    Europe  

View report >

Biosimilar Industry in EU

  • December 2017
    43 pages
  • Biosimilar  

    Therapy  

    Monoclonal Anti...  

  • European Union  

    Europe  

    World  

View report >

Hepatitis Statistics and Therapy Market

  • October 2017
    2 pages
  • Hepatitis  

    Therapy  

    Cancer  

  • Europe  

    United States  

    China  

View report >

Global Hepatitis Statistics - Forecast

  • September 2017
    2 pages
  • Hepatitis  

    Targeted Therap...  

  • Europe  

    United States  

    World  

View report >

Chemotherapy Market in Europe

  • August 2017
    9 pages
  • Chemotherapy  

  • Europe  

View report >

Search in Oncology Industry (60 reports)

Topics under Oncology

Parent industry: Therapy
Related industries: 

43 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 599 - $ 10000)

Drug Analysis: Ofatumumab

Drug Analysis: Ofatumumab

  • $ 10000
  • Industry report
  • November 2017
  • by Datamonitor Healthcare

Drug OverviewOfatumumab (Genmab/Novartis) is a fully human immunoglobulin G1 and high-affinity antibody that targets a novel epitope on cluster of differentiation (CD)20 on the B-cell membrane. Ofatumuma ...

2018 Pap Smear/HPV Market: US, Europe (France, Germany, ... $ 3500 June 2018

Burkitt Lymphoma Drug Profiles and Clinical Trials- Glo ... $ 2000 January 2018

Mantle Cell Lymphoma Drug Profiles and Clinical Trials- ... $ 2000 January 2018

Global Leiomyosarcoma Clinical Trials Research Trends- ... $ 2000 August 2017

Europe Cancer Immunotherapy MarketAnalysis (2017-2023) $ 1500 December 2017

Atopic Dermatitis: Update Bulletin #1 $ 1111 December 2017

Rheumatoid Arthritis: Update Bulletin #3 $ 1111 December 2017

Colorectal Cancer: Update Bulletin #1 $ 1111 December 2017

Chronic Migraine Survey $ 599 March 2017


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on